We are live on ! Find out more
ITCI

Intra-Cellular Therapies Inc.
ITCI

Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

126 hedge funds and large institutions have $298M invested in Intra-Cellular Therapies Inc. in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 35 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 35

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0% more funds holding

Funds holding: 126 → 126 (0)

40% less capital invested

Capital invested by funds: $498M → $298M (-$200M)

41% less call options, than puts

Call options by funds: $15.4M | Put options by funds: $26.2M

Holders
126
Holders Change
–
Holders Change %
0%
% of All Funds
2.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
42
Reduced
35
Closed
25
Calls
$15.4M
Puts
$26.2M
Net Calls
-$10.8M
Net Calls Change
-$40.6M

Top Buyers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
+$16M
2
Millennium Management
Millennium Management
New York
+$10.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$7.53M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.37M
5
CS
Candriam SCA
Luxembourg
+$3.84M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.5M
2
Franklin Resources
Franklin Resources
California
-$7.98M
3
FMBTD
First Midwest Bank Trust Division
Illinois
-$7.79M
4
CCI
Columbus Circle Investors
-$6.93M
5
N
Nuveen
North Carolina
-$3.61M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
76
Wells Fargo
California
$175K +$26.7K +2,789 +13%
CBA
77
Coastal Bridge Advisors
Connecticut
$161K – – –
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$160K – – –
VEA
79
Virtus ETF Advisers
New York
$151K -$10.8K -1,125 -5%
ProShare Advisors
80
ProShare Advisors
Maryland
$149K -$7.91K -825 -4%
CCM
81
Consonance Capital Management
New York
$149K +$192K +20,000 New
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$147K -$13.8K -1,435 -7%
MIM
83
MetLife Investment Management
New Jersey
$146K – – –
VOYA Investment Management
84
VOYA Investment Management
Georgia
$146K – – –
Walleye Capital
85
Walleye Capital
New York
$137K +$175K +18,300 New
TI
86
Trexquant Investment
Connecticut
$137K +$176K +18,383 New
Legal & General Group
87
Legal & General Group
United Kingdom
$136K +$20.8K +2,171 +14%
AWCI
88
Alpine Woods Capital Investors
New York
$134K -$1.92K -200 -1%
LPL Financial
89
LPL Financial
California
$134K +$172K +17,973 New
AG
90
Aperio Group
California
$121K -$8.76K -914 -5%
Citigroup
91
Citigroup
New York
$117K -$4.1K -428 -3%
SC
92
Slow Capital
California
$112K – – –
MLICM
93
Metropolitan Life Insurance Company (MetLife)
New York
$105K – – –
Stifel Financial
94
Stifel Financial
Missouri
$101K -$11.5K -1,200 -8%
QT
95
Quantbot Technologies
New York
$98K +$126K +13,174 New
Rafferty Asset Management
96
Rafferty Asset Management
New York
$94K +$121K +12,572 New
ECM
97
ExodusPoint Capital Management
New York
$92K +$17.8K +1,857 +18%
DTL
98
Dynamic Technology Lab
Singapore
$88K +$112K +11,716 New
CPP
99
Crow Point Partners
Massachusetts
$86K – – –
GAM
100
Gemmer Asset Management
California
$82K +$9.59K +1,000 +10%
2 3
4
5 6

ITCI Hedge Fund Activity: Q3 2019 in Review

126 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Intra-Cellular Therapies Inc. (ITCI) for Q3 2019, worth a combined $298M — down 40% from $498M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ITCI positions and 25 closed out — a net gain of 1 holder — while 42 added to existing stakes and 35 trimmed.

The largest buyer was Wasatch Advisors, adding an estimated $16M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.

  • 126 institutional investors held Intra-Cellular Therapies Inc. (ITCI) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $298M of Intra-Cellular Therapies Inc. stock for Q3 2019, down 40% quarter-over-quarter.
  • 26 funds opened new Intra-Cellular Therapies Inc. positions in Q3 2019 and 25 closed out, a net change of +1 holder.
  • The largest Intra-Cellular Therapies Inc. buyer in Q3 2019 was Wasatch Advisors, an estimated $16M added.
  • The largest Intra-Cellular Therapies Inc. seller in Q3 2019 was Fidelity Investments, an estimated $20.5M sold.

Based on aggregated 13F filings for Q3 2019.